documented in former preterm infants. 3, 4 This phenomenon is probably a marker for prolonged cardiorespiratory instability beyond preterm birth. We have speculated that persistent apnea may even be a marker of subtle neurodevelopmental problems. 5 There is, however, no evidence that the recognition of persistent cardiorespiratory events is a useful diagnostic marker for SIDS. So the search continues for an appropriate means to screen infants at high risk for SIDS.
The recently reported study by Schwartz et al revives interest in one potential cause for SIDS, namely that infants with the syndrome of congenital QT prolongation are at risk for lethal ventricular arrhythmias. 6 The finding of prolongation of QT in 50% of term infants who died of SIDS suggests that this abnormality could be a marker of risk for SIDS. 6 A limitation of the Schwartz study was the exclusion of the majority of preterm and ill infants who are at highest risk for SIDS. 6 The finding that an elevated QT interval is a strong risk factor for SIDS thus may not be generalizable to the groups of infants at greatest risk. Before we assume that a cause-and-effect relationship between prolonged QT interval and SIDS exists, we must consider the gaps in the chain of evidence. The logical conclusion from the study of Schwartz et al is that arrhythmia is the cause of death in the infants with prolonged QT. 6 There is, however, no evidence for lethal arrhythmias as precipitating events in infants who have died of SIDS while on cardiorespiratory monitors, nor have ventricular arrhythmias been described in patients who have been evaluated after survival of an acute life-threatening event. 7, 8 A biological marker for SIDS may be important for disease screening, even if not implicated directly in the causal pathway. Schwartz et al cautiously discuss some of the issues involved in using electrocardiogram (ECG) analysis as just such a biological marker for infant screening. 6 The accompanying editorial in the New England Journal of Medicine by Towbin and Friedman also suggests a role for screening for prolonged QT intervals, and suggests the need to develop an "abbreviated ECG" for such purposes. 9 However, the editorial assertion that no surviving infant or infant who died of other causes had a prolonged QT interval, is contradicted by careful evaluation of the available data of Schwartz et al which suggest that approximately 800 surviving infants had elevated QT intervals. 6 The latter yields a positive predictive value of 1.5%. In other words, 98.5% of positive screening studies will prove to be false-positives.
It is well-recognized that the development of screening tests for rare entities such as SIDS requires tests with high levels of specificity to reduce falsepositives, and thus, reduce the number of patients/ caregivers who are inappropriately subjected to additional tests and psychological stress. Additional criteria necessary before adoption of screening tests are evidence of reliability of the test, and demonstration of the feasibility and utility of the screening program. There are no data that support the utility of interventions to reduce QT duration on SIDS incidence, nor are there data that address the utility of monitoring of such "high-risk" infants so as to prevent death. Thus, the data suggest that ECG analysis for QT interval does not meet criteria for an acceptable screening test.
We agree with the comments by Schwartz et al that susceptibility to SIDS may be quite complex and that identifying high-risk infants who may be especially vulnerable to underlying cardiac disturbances is important. Further understanding of individual susceptibility, especially in preterm infants, is needed both to clarify pathogenesis and to develop responsible public health practices. 
Prolongation of the QT Interval and the Sudden Infant Death Syndrome
and careful scrutiny of the data and its interpretation is required.
The long QT syndrome (LQTS) is a rare and frightening genetic disorder that leads to ventricular arrhythmias, typically torsade de pointe, manifested by repeated syncope and eventual death in many victims. There are no physical findings and the only other manifestation is prolongation of the QT interval on the electrocardiogram, corrected for rate (QTc). In 1976, Schwartz proposed that a developmental form of this disorder could account for SIDS, 2 involving asymmetric development of the sympathetic nerves of the heart. It is worth noting that such asymmetry has not been confirmed even in the genetic syndrome, 3 and recent research has identified the abnormality to be on a molecular level, ionic channels in myocytes. 4 Schwartz and his colleagues commenced a prospective study of ECGs in normal neonates and have published five reports of the results, culminating in the recent article. 1 There are several problems with these ongoing studies, but the most damning is the lack of independent confirmation in the past 22 years. In fact, there have been four prospective studies [5] [6] [7] [8] that have contradicted the Italian data. Another important deficiency of the developmental long QT theory is the failure to document ventricular arrhythmias-the mechanism of death for patients with prolonged QTc-nor has anyone else recorded ventricular arrhythmias in infants at risk for SIDS, although there have been thousands of infants monitored electronically in hospital and at home. In contrast, patients with clinically established LQTS have multiple episodes of ventricular arrhythmias; death without prior arrhythmia is uncommon. 9 A substantial objection to the case selection in the study by Schwartz and colleagues is that two of their cases appear to be instances of the true syndrome (LQTS), which should make them ineligible for the diagnosis of SIDS. Both these infants had a QTc Ͼ500 msec and would be judged to have the syndrome by most cardiologists. 9 Although Schwartz et al state that they ruled out LQTS based on family history, only 39% of all established LQTS patients have a positive family history. 9 Finally, even if the hypothesis were reasonable and screening successful, prevention of death cannot be assured, since Moss and Robinson, 10 based on the largest registry of LQTS in the world, found no statistically significant benefit of any treatment for the syndrome, let alone preventing SIDS. It is unthinkable to prescribe ␤-blockers for thousands of asymptomatic infants with a statistical "abnormality" based on a very subjective measurement with a very wide range of normal. It is equally unthinkable to squander medical resources for screening based on an unsubstantiated study.
Prolonged QTc as a Risk Factor for SIDS
ABBREVIATIONS. SIDS, sudden infant death syndrome; ECG, electrocardiogram. P eter Schwartz and colleagues 1 have recently published the results of a 19-year study relating prolongation of the QTc to the sudden infant death syndrome (SIDS). The authors performed electrocardiograms (ECGs) on 3-to 4-dayold infants and obtained information on whether they had survived to their first birthday for 33 034 infants. The authors report the QTc for the 24 SIDS deaths, the other 10 deaths, and a group of 9725 surviving infants. Half of the SIDS deaths had a QTc of Ͼ440 msec (97.5 centile), while the QTc in none of the other deaths was Ͼ420 msec. They cautiously propose use of a prolonged QTc in the newborn period as a marker for risk for SIDS and suggest treatment with ␤-blockers for infants in epidemiologic risk groups.
The first consideration in commenting on this 
